Lee este artículo en español. If you love great deals, fast shipping, and streaming movies and music, an Amazon Prime membership might be perfect for you. From electronics, digital entertainment, to ...

In a report released today, Sarah Schram from William Blair maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s shares closed yesterday at $0.49. Effectively ...

As he walked out of the House of Commons on Monday, March 10, following his successor's election a day prior, Canada's outgoing prime minister picked up his Parliament chair, carried it with him ...

A digital therapeutics start-up which uses augmented reality (AR) glasses to aid people suffering from disorders including Parkinson's disease and multiple sclerosis will this week announce a £ ...

As a hub for next-generation therapeutics, the facility aims to foster collaborations between Entos, Canadian academic institutions, and its industry partners. This effort will build expertise and ...

Former central banker Mark Carney will become the next prime minister of Canada after winning the race to lead the country’s governing Liberal Party on Sunday. In his first speech as party ...

TORONTO: Former central banker Mark Carney will become Canada’s next prime minister after a Liberal Party leadership vote in a landslide. Carney is 59. He was born in Fort Smith, Northwest ...

TORONTO (AP) — Former central banker Mark Carney will become Canada’s next prime minister after the governing Liberal Party elected him its leader Sunday as the country deals with U.S ...

A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain ...

Amazon’s new and improved Alexa experience, Alexa+, starts at $19.99 per month, or free for Amazon Prime subscribers. It’ll roll out in early access beginning next month in the U.S., and then ...

Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...